Latest Financials News

Page 671 of 1331
Redcastle Resources Limited has resumed trading on the ASX following key announcements about a joint venture farm-out, a strategic placement, and a major gold project acquisition.
Maxwell Dee
Maxwell Dee
20 Aug 2025
Genetic Technologies Limited reports a 36% increase in half-year losses amid voluntary administration, followed by a recapitalisation and sale of core assets. The company pivots towards new financial services acquisitions under fresh leadership.
Ada Torres
Ada Torres
20 Aug 2025
WOTSO’s FY25 results reveal a robust 14% increase in underlying EBITDA, driven by its expanding flexible workspace portfolio now spanning 31 locations. Strategic investments and partnerships underpin a confident outlook toward $58 million revenue by FY30.
Eva Park
Eva Park
20 Aug 2025
Saunders International reported a modest revenue dip and sharp profit decline in FY2025, offset by a transformative acquisition that expands its water infrastructure footprint and doubles its project pipeline.
Victor Sage
Victor Sage
20 Aug 2025
Frontier Digital Ventures has uncovered apparent misappropriation of approximately USD 430,000 within its Colombian business, Fincaraiz, prompting an ongoing investigation and operational safeguards.
Sophie Babbage
Sophie Babbage
20 Aug 2025
Vicinity Centres confirms its distribution reinvestment plan will apply to the FY25 final distribution, offering investors a 1% discount on new securities issued under the plan.
Eva Park
Eva Park
20 Aug 2025
WOTSO’s FY2025 results reveal an 11% revenue decline but a significantly reduced net loss, alongside a raised distribution payout, signaling cautious optimism amid market challenges.
Eva Park
Eva Park
20 Aug 2025
Saunders International reported a slight revenue dip and a sharp EBITDA decline in FY2025, offset by a transformative acquisition that dramatically expands its order book and pipeline.
Victor Sage
Victor Sage
20 Aug 2025
Vicinity Centres reported a robust FY25 with statutory net profit surging to $1 billion, driven by strategic portfolio repositioning and strong retail sales growth. The company’s focus on premium assets and disciplined capital management sets the stage for continued growth in FY26.
Eva Park
Eva Park
20 Aug 2025
Invion Limited secures a pivotal FDA Orphan Drug Designation for its lead candidate INV043, targeting anal cancer with promising preclinical results and a fast-tracked development path.
Ada Torres
Ada Torres
20 Aug 2025
Saunders International reported a sharp 77.9% drop in net profit for FY2025, even as revenue dipped only slightly by 0.7%. The company declared a final dividend, signaling cautious optimism amid earnings pressure.
Victor Sage
Victor Sage
20 Aug 2025
Vicinity Centres reported a doubling of net profit and delivered funds from operations at the top of guidance, underpinned by strategic acquisitions and strong portfolio performance.
Eva Park
Eva Park
20 Aug 2025